Drug intelligence / Profile preview

iotroxic acid

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Intravenous
01

Overview

Iotroxic acid is an iodinated, water-soluble contrast medium used primarily for intravenous cholangiography and cholecystography. As a triiodinated benzoic acid derivative, it is characterized by high biliary excretion following intravenous administration, which allows for the opacification and detailed visualization of the bile ducts and gallbladder during X-ray or computed tomography (CT) imaging. It was historically utilized in drip infusion cholangiography (DIC) to evaluate biliary anatomy, detect gallstones (choledocholithiasis), and identify pancreaticobiliary maljunctions, particularly prior to laparoscopic procedures. Developed by Schering AG, it was marketed under the brand name Biliscopin. While effective, its clinical use has significantly declined with the advent of non-invasive imaging modalities such as magnetic resonance cholangiopancreatography (MRCP).

Brand names
Biliscopin
Other names
iotroxic acid megluminemeglumine iotroxateiotroxate meglumine

Beyond the preview

Go deeper on iotroxic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iotroxic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call